Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05673135

The Outcomes of Hypertension in Obese Versus Non-obese Pregnant Women

Conditions: Hypertension in Pregnancy

Sex: Female
Ages: 25 Years – 35 Years
Phase: NA
Enrollment: 260
Sponsor: Assiut University

Location: Egypt

Summary

Hypertensive disorders of pregnancy, include pre-existing and gestational hypertension, preeclampsia, and eclampsia, it complicates up to 10% of pregnancies and represents a significant cause of maternal and perinatal morbidity and mortality. Following the "National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy" recommendation is currently a systolic blood pressure (SBP) ⩾ of 140 mmHg and diastolic blood pressure (DBP) ⩾ of 90 mmHg. The diagnosis generally requires two separate measurements. Accepted across international guidelines are the following four categories: Chronic/pre-existing hypertension (Hypertension discovered preconception or prior to 20 weeks gestation), Gestational hypertension (Hypertension that appears de novo after 20 weeks gestation and normalizes after pregnancy), Preeclampsia-eclampsia (De novo hypertension after 20 weeks' gestation accompanied by proteinuria, other features of maternal organ dysfunction or uteroplacental dysfunction), Chronic/pre-existing hypertension with superimposed preeclampsia-eclampsia. Over the past 2 decades, extensive epidemiologic studies have clearly established that obesity is a major risk for gestational hypertension and preeclampsia. The risk of preeclampsia typically doubles with each 5-7 kg/m2 increase in pre-pregnancy. The mechanisms have only been partially explored; increased cytokine-mediated inflammation and oxidative stress, increased shear stress, dyslipidemia, and increased sympathetic activity1 have all been proposed as possible pathways. Few studies have examined the relationship between pre-pregnancy BMI, gestational weight gain (GWG), and the risk of preeclampsia. So, our study aims to evaluate the adverse maternal and fetal outcomes related to hypertension in obese and non-obese pregnant women.

Eligibility Criteria

Inclusion Criteria:Women aged from 20-35 years.Pregnant women from 28-30 weeks.Pregnant women with a singleton pregnancy.Women with chronic or gestational hypertension.Women with normal baseline investigations (uncomplicated hypertension).Obese women and non-obese women.Exclusion Criteria:Women with preeclampsia/eclampsia.Women need urgent termination of pregnancy.Women with co-morbidities such as diabetes, renal diseases, cardiac ...etc.Women with confirmed fetal malformation.Women who will refuse to participate.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05673135). StuddyBuddy aggregates publicly available trial information.